Cherry Tree Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$725K Sell
8,364
-2,750
-25% -$263K 0.15% 78
2025
Q4
$1.07M Sell
11,114
-342
-3% -$33.2K 0.23% 72
2025
Q3
$1.09M Hold
11,456
0.24% 68
2025
Q2
$999K Sell
11,456
-8
-0.1% -$678 0.23% 69
2025
Q1
$1.03M Hold
11,464
0.25% 69
2024
Q4
$916K Buy
11,464
+8
+0.1% +$693 0.23% 71
2024
Q3
$1.03M Sell
11,456
-1,152
-9% -$96.9K 0.24% 70
2024
Q2
$992K Sell
12,608
-2,527
-17% -$207K 0.25% 66
2024
Q1
$1.32M Hold
15,135
0.33% 59
2023
Q4
$1.25M Hold
15,135
0.33% 57
2023
Q3
$1.19M Buy
15,135
+3,474
+30% +$291K 0.35% 49
2023
Q2
$1.03M Buy
+11,661
New +$1M 0.3% 55

Other funds holding MDT

Cherry Tree Wealth Management's MDT Position: Q1 2026 in Review

Cherry Tree Wealth Management reduced its Medtronic (MDT) stake by 25% in Q1 2026, selling an estimated $263K and leaving 8,364 shares worth $725K. The position accounts for 0.15% of the portfolio, ranked #78.

Cherry Tree Wealth Management first reported a position in MDT in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.32M in Q1 2024. 2,248 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Cherry Tree Wealth Management held 8,364 shares of Medtronic worth $725K as of Q1 2026.
  • Cherry Tree Wealth Management sold 2,750 Medtronic shares in Q1 2026, an estimated $263K.
  • Medtronic made up 0.15% of Cherry Tree Wealth Management's portfolio in Q1 2026, its #78 holding.
  • Cherry Tree Wealth Management first reported a position in Medtronic in Q2 2023 and has held it in 12 quarters since.
  • Cherry Tree Wealth Management's Medtronic position peaked at $1.32M in Q1 2024.
  • 2,248 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Cherry Tree Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.